Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 8,250 | 7,150 | 2,250 | 4,750 | 125,000 |
| Gross Profit | 8,250 | 7,150 | 2,250 | 4,750 | 125,000 |
| Operating Expenses | 99,499 | 96,619 | 101,627 | 91,118 | 89,683 |
| Operating Income | -91,249 | -89,469 | -99,377 | -86,368 | 35,317 |
| Interest Expense | 0 | 0 | 0 | 25 | 91 |
| Other Income | 341 | 442 | 537 | 420 | 2,664 |
| Pre-tax Income | -90,908 | -89,027 | -98,840 | -85,973 | 37,890 |
| Net Income Continuous | -90,908 | -89,027 | -98,840 | -85,973 | 37,890 |
| Net Income | $-90,908 | $-89,027 | $-98,840 | $-85,973 | $37,890 |
| EPS Basic Total Ops | -10.40 | -10.20 | -13.20 | -13.60 | 7.30 |
| EPS Basic Continuous Ops | -10.37 | -10.20 | -13.18 | -13.58 | 7.28 |
| EPS Diluted Total Ops | -10.40 | -10.20 | -13.20 | -13.60 | 7.20 |
| EPS Diluted Continuous Ops | -10.37 | -10.20 | -13.18 | -13.58 | 7.21 |
| EBITDA(a) | $-88,890 | $-86,877 | $-96,944 | $-84,413 | $36,634 |